David Schrama

20PUBLICATIONS
57CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Dec 15, 2025
RB1 inactivation in cutaneous carcinomas.

Tiffany Liv, Antoine Touzé, David Schrama

|Jul 11, 2024
Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1.

Kuan Cheok Lei, Nalini Srinivas, Mitalee Chandra

|May 25, 2024
Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update.

Thilo Gambichler, David Schrama, Riina Käpynen

|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.

Simone Wendlinger, Jonas Wohlfarth, Claudia Siedel

|Apr 22, 2024
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates.

Jürgen C Becker, Andreas Stang, David Schrama

|Sep 11, 2023
Current and preclinical treatment options for Merkel cell carcinoma.

Büke Celikdemir, Roland Houben, Thibault Kervarrec

Pageof 4

Frequent Collaborators

10 joint publications

Roland Houben

10 joint publications

Thibault Kervarrec

5 joint publications

Jürgen C Becker

3 joint publications

Mahtab Samimi